J2KBIO (420570) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, J2KBIO (420570) reported revenue of 33.0 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202533.0 billion KRW2.9 billion KRW2.7 billion KRW[source]
202433.1 billion KRW3.6 billion KRW-1.7 billion KRW[source]
202328.5 billion KRW5.6 billion KRW4.8 billion KRW[source]
202216.0 billion KRW2.3 billion KRW2.1 billion KRW—
202114.2 billion KRW1.9 billion KRW1.6 billion KRW—

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202539.0 billion KRW3.7 billion KRW35.3 billion KRW[source]
202436.3 billion KRW4.3 billion KRW32.1 billion KRW[source]
202321.6 billion KRW3.8 billion KRW17.9 billion KRW[source]
2022————
2021————

Years without a source link are outside the DART financial API collection period.

Balance sheet figures for the relevant year were not collected.

Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice